|
|
Volumn 3, Issue 3, 2001, Pages 377-380
|
|
The cardiac insufficiency talinolol study (CITAS) study design
a
|
|
Author keywords
Chronic heart failure; Exercise capacity; Talinolol
|
|
Indexed keywords
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
DIGOXIN;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
NITRATE;
TALINOLOL;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG SAFETY;
EXERCISE;
FEMALE;
HEART FAILURE;
HEART LEFT VENTRICLE FUNCTION;
HUMAN;
ISCHEMIC HEART DISEASE;
MAJOR CLINICAL STUDY;
MALE;
MORTALITY;
PRIORITY JOURNAL;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
ADOLESCENT;
ADRENERGIC BETA-ANTAGONISTS;
ADULT;
BLOOD PRESSURE;
DOUBLE-BLIND METHOD;
ENDPOINT DETERMINATION;
FEMALE;
FOLLOW-UP STUDIES;
HEART FAILURE, CONGESTIVE;
HEART RATE;
HUMANS;
MALE;
MIDDLE AGED;
PROPANOLAMINES;
RESEARCH DESIGN;
STROKE VOLUME;
|
|
EID: 0034828163
PISSN: 13889842
EISSN: None
Source Type: Journal
DOI: 10.1016/S1388-9842(01)00133-7 Document Type: Article |
|
Times cited : (11)
|
|
References (9)
|
